Assessing Spyre Therapeutics (SYRE) Valuation After Recent Share Price Rebound
Spyre Therapeutics (SYRE) shares are showing a bit of movement lately, with the stock gaining nearly 1% on the day. Over the past month, SYRE has climbed 27%, despite some longer-term volatility. This continues to draw the attention of investors.
See our latest analysis for Spyre Therapeutics.
Despite a steep 1-year total shareholder return of -43.1%, momentum has been shifting lately. Spyre Therapeutics notched a 27.4% gain in its 30-day share price return and a notable 48.6% rise over the last 90 days, suggesting renewed optimism around the stock after a rough stretch.
If you’re curious to see what else is moving in the biotech and pharma space, consider exploring opportunities through our healthcare stocks screener: See the full list…
